AU618962B2 - Method for the isolation of active enzyme(s) from krill tissue - Google Patents

Method for the isolation of active enzyme(s) from krill tissue Download PDF

Info

Publication number
AU618962B2
AU618962B2 AU22597/88A AU2259788A AU618962B2 AU 618962 B2 AU618962 B2 AU 618962B2 AU 22597/88 A AU22597/88 A AU 22597/88A AU 2259788 A AU2259788 A AU 2259788A AU 618962 B2 AU618962 B2 AU 618962B2
Authority
AU
Australia
Prior art keywords
krill
document
international
enzymes
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU22597/88A
Other versions
AU2259788A (en
Inventor
Thomas Berglindh
Lars Hellgren
Bjorn Karlstam
Viggo Mohr
Jan Vincent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lh Forskning AB
Parti- Transaction AB
Bioscan AS
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8703064A external-priority patent/SE8703064D0/en
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of AU2259788A publication Critical patent/AU2259788A/en
Application granted granted Critical
Publication of AU618962B2 publication Critical patent/AU618962B2/en
Assigned to BIOSCAN A.S., Parti- Transaction AB, AKTIEBOLAGET L.H. FORSKNING reassignment BIOSCAN A.S. Alteration of Name(s) in Register under S187 Assignors: PHARMACIA AB
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Description

the invention the subject of the application.
DECLARED at Uppsala this 27th day of December A.D. 1989 PHARMACIA AB through j; 6 FF mu V i AU-AI-22597/88 WORLD INTELLECTUAL PROPERTY ORGANIZATION International Bureau PCT 6 INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (51) International Patent Classification 4 C12N 9/00, 9/14, A61K 37/48 (11) International Publication Number: Al (43) fU nat al iic& DfI 9 WO 89/ 01031 (21) International Application Number: PCT/SE88/00374 (22) International Filing Date: 8 July 1988 (08.07.88) (31) Priority Application Number: 8703064-9 (32) Priority Date: 6 August 1987 (06.08.87) (33) Priority Country: SE (71) Applicant (for all designated States except US): PHAR- MACIA AB [SE/SE]; S-751 82 Uppsala (SE).
(72) Inventors; and Inventors/Applicants (for US only): MOHR, Viggo [NO/ NO]; S:t Jorgensveita 6A, N-7000 Trondheim (NO).
VINCENT, Jan [SE/SE]; Ulvsundavagen 49, S-161 Bromma HELLGREN, Lars [SE/SE]; Bronsgjutaregatan 13, S-421 63 V:A Fr6iunda KARL- STAM, Bj5rn [SE/SE]; Spiltvagen 7, S-740 30 Bj6rklinge BERGLINDH, Thomas [SE/SE]; Ripvigen 5, S-752 52 Uppsala (SE).
(74) Agents: BERGANDER, S-751 82 Uppsala (SE).
(81) Designated States: AT (European patent), AU, BE (European patent), CH (European patent), DE (European patent), FR (European patent), GB (European patent), IT (European patent), JP, LU (European patent), NL (European patent), SE (European patent),
US.
Published With international search report.
.U J.p. 20 APR 1989
AUSTRALIAN
1 MAR 1989 PATENT OFFICE (54) Title: METHOD FOR THE ISOLATION OF ACTIVE ENZYME(S) FROM KRILL TISSUE (57) Abstract Method for the isolation of active enzyme(s) from an animal of the order Euphausiaceae, characterized in that the animals, or parts of the animals are induced to autolyse to the formation of distinct oil and aqueous phases, whereupon the phases are separated and the active enzyme(s) is(are) isolated from the appropriate phases-by conventional methods.
A At WO89/01031 PCT/SE88/00374 Method for the isolation of active enzyme(s) from krill tissue.
Field of invention This invention relates to an improvement in the isolation of active enzymes from aquatic animals of the order Euphausiaceae, commonly called krill. The method of the invention is adapted for enzymes and enzyme precursors from different krill tissues, particularly for those enzymes that originate from the digestive apparatus. The enzymes to be isolated may be different hydrolases, such as proteases, lipases, nucleaser, polysaccharidases etc, and other enzymes that effect breakdown of biologic substances e.g. protein, lipid, polysaccharides and nucleic acids, or their constituents.
General background Animals of the order Euphausiaceae, and in particular Antarctic krill represented by Euphausia superba and Euphausia crystallorophias, and North Atlantic krill represented by Meganyctiphanes norvegica and Thyssanoessa species, have become increasingly promising as a source of biologically active substances. They are known to contain very effective hydrolases. The high efficiency of mixtures of endo- and exopeptidases of krill in degrading proteinaceous substrates has been demonstrated (Ellingsen, 1982; Saether, 1986; Ellingsen Mohr, 1987; and Saether, Ellingsen Mohr, 198 7 The peptide hydrolases of krill effect an extensive breakdown of krill tissues and proteins post mortem, resulting in the release of free amino acids and shorter peptides.
Visually this is observed as an autolysis. The phenomenon has been suggested to be employed for the preparation of free amino acids on an industrial scale (Ellingsen Mohr, 1979).
WO 89/01031 2 PCT/SE88/0D374 The conditions effecting autolysis of krill have been extensively studied (Ellingsen Mohr, 1979; Ellingsen, 1982; Ellingsen Mohr, 1987 and Saether, Ellingsen Mohr, 1987). The latter publication relates to North Atlantic krill, whereas the former publications deal with Antarctic krill. The rate of autolysis, as measured by the amount of free amino acids released into solution, depends on a series of factors, e.g. temperature, time of incubation, pH and whether whole krill or homogenate is being autolyzed (Ellingsen, 1982).
Substantial evidence is now starting to accumulate that peptide hydrolases from Antarctic krill are superior as debriding agents for wound compared to the enzyme preparations currently in clinical use for this purpose. The general picture which emerges from studies in vitro and clinically (Hellgren, Mohr Vincent, 1986 and 1987, respectively) is that the debridement with the krill enzymes proceeds at a higher rate, and results in a more complete breakdown of the necrotic tissue than that obtained by other clinically used enzymatic debriders.
The peptide hydrolases of krill which are of particular interest therapeutically have recently been isolated and studied in considerable detail (Osnes Mohr, 1985a Osnes Mohr, 1985b; Osnes Mohr, 1986; Osnes, Ellingsen Mohr, 1986). As shown in these studies, the major krill peptide hydrolases include three different trypsin-like serine proteinases, two carboxypeptidase A-type of enzymes, two carboxypeptidase B-type of enzymes and one aminopeptidase.
The enzymes seem to originate almost exclusively from the digestive tract of the krill, and thus seem to constitute enzymes of the digestive apparatus of the animals (Ellingsen, 1982; Grundseth V.Mohr, unpublished).
Among other enzyme activities that have been measured in different preparations of krill are various polysaccharidase WO 89/01031 3 PCT/SE88/00374 activities (Karlstam, 1988 and Chen Gau 1981), lipase activity (Nagayama 1979), ribonuclease activity (Van 1982) etc.
The krill peptide hydrolases seem to possess a property which is highly valuable and essential for the use of the mixture of these enzymes for practical applications. The simple digestive system in krill probably implies that the individual enzymes are mutually protected against the degrading effect of each other. Thus, in contrast to enzymes from the mammalian digestive tract, it has been demonstrated conclusively that the krill peptide hydrolases show considerable inertness to breakdown and loss of activity when they are mixed (Osnes Mohr, 1985ab; Osnes, 1986; Osnes, Ellingsen Mohr, 1986).
The krill enzymes which are of particular interest for medical and technical applications are usually water soluble, and can be isolated by extracting whole krill, homogenized krill or parts of krill with either water, or buffered, aqueous solutions, followed by isolation and purification of the individual enzymes or groups of enzymes by suitable, established methods (Osnes Mohr, 1985a). Although such procedures may be satisfactory for laboratory work, large scale industrial processes based on this procedure may represent a problem. The problems relate to the fact that important species of krill usually have a high lipid content, of which glycerophospholipids may make up a considerable proportion (Ellingsen, 1982; Saether, 1986). When extracting different forms of krill with aqueous solvents glycerophospholipids tend to associate with protein, and after centrifugation such extracts may typically consist of a top layer containing oil, below which is a layer rich in glycerophospholipids and protein, below which is an aqueous phase and, finally, at the bottom, an insoluble sediment.
WO 89/01031 PCT/SE88/00374 Due to the protein-glycerophospholipid association the phase separation will be far from distinct. Efficient separation of.the aqueous phase containing the enzymes therefor represents a problem in an industrial process. Furthermore, in addition to the enzymes, the aqueous phase contains large amounts of soluble proteins, including muscle proteins of the krill.
The- separation of active enzymes from other proteins require expensive processing technology and, in addition, the non-enzymatic proteins obtained as by-products in this type of process occur in a form which generally has a low market value. Thus, large-scale isolation procedures based on extraction of fresh krill with water may not secure that the therapeutically and technically important enzymes can be isolated in a way which is economically feasible. These problems may be partly overcome by defatting the unhomogenized krill and/or the homogenized with a lipophilic/hydrophobic solvent carbon tetrachloride). However, this way of processing krill will give at least one or two extra steps.
The promising prospects of using the digestive enzymes of krill as novel preparations for medical and technical use, stress the need for effective.methods aimed at isolating and purifying the krill enzymes.
The invention The present invention proposes a novel procedure for isolating active enzymes from krill without facing the drawbacks mentioned above. The invention utilizes the well-documented fact that the digestive enzymes of krill effect an extensive breakdown of the krill tissues post mortem, yielding a liquefied system, comprising an oil, an aqueous and an insoluble phase sediment). The invention takes advantage of the fact that the system formed after autolysis under efficient conditions may form distinct phases (phase boundaries).
A physical separation can effectively be performed by simple process technology, e.g. centrifugation, and without the WO 89/01031 5 PCT/SE88/00374 problems in particular caused by the protein/glycerophospholipid layer described when extracting fresh krill as outlined previously. Prior art methods have aimed at avoiding autolysis.
The invention employs autolysis as a prestep to facilitate separation and extraction. The need for separate defatting steps is minimized.
The method of the invention accordingly is characterized by whole krill, homogenized krill, squeezed krill or similarly treated parts of krill (preferably containing the digestive tract) being permitted to autolyse so that a system comprising an oil phase and an aqueous phase is formed having a distinct phase boundary therebetween. High levels of enzyme activity is retained in the aqueous phase after autolysis. The effic.ent phase separation is probably due to the degradation of glycerophospholipid by krill phopholipase. After'the autolysis step, the enzyme-containing aqueous phase is separated from other phases present, followed by the isolation of the enzyme(s) contemplated by conventional procedures. In case the enzyme(s) to be isolated is partitioned to the oil phase conventional isolation procedures known per se is applied to the oil phase. The separation of the individual phases of the autolysate can be carried out be several different methods. Particularly well suited are those exposing the autolysate to centrifugal forces, but other procedures e.g. sedimentation and flotation may also be applicable.
The yield of enzymes obtained depends on time of incubation (autolysis), temperature, pH, type of krill preparation (whole, homogenized or squeezed krill) and the specific enzyme(s) to be isolated.
Generally the conditions for the autolysis to proceed properly should be as below.
1< L6 WO 89/01031 6 PCT/SE88/00374 Temperature: The lower limit is 15 OC with a preference for temperatures above 20 The upper limit is 70 0 C, perferably below 45 0 C. Certain krill enzymes have been shown to be heat-sensitive so that when such enzymes are to be retained in the end product, the temperature has to be carefully selected. For instance, if krill hyaluronidase or krill amylase is to be isolated it is recommended to run the autolysis below 45 The krill proteases are quite heatstable with a temperature optimum around 55-60 0 C. This means that if krill proteases are the important enzymes in the end product, the autolysis can be performed up to 70 °C.
If a mixture of enzyme(s) are to be isolated and one of them is heat-sensitive, the temperature should be considerable lower, e.g. below 45 0 C. In conclusion the temperature should be selected in the range 15-70 preferably 20-45 °C.
pH: This value should be selected in the range of 6-8,5, although autolysis may also be performed down to pH 5. The preferred range is 6-7,5. We have performed experiments at the pH-optimum for the proteases (pH in order to work effectively. However, at this pH-value the phase separation after autolysis was not satisfactory. This might indicate that enzymes other than the proteases are important to obtain an efficient autolysis phospholipases).
Time for incubation: This variable should be selected so as to result in the most economic feasible process. By selecting pH and temperature within the ranges given above incubation times of 1 h 2 weeks, with preference for 5-48 hours, can be accomplished.
It is important to investigate in pretrial experiments that the combination of temperature, pH and time of incubation will not lead to significant degradation and/or inactivation of the enzyme(s) intended to be isolated. Accordingly each enzyme or enzyme mixture has its own optimal conditions within the above-mentioned limits in order to reach the best quality and yield.
i i i w6)89/01031 7 PCT/SE88/00374 Depending on the particular enzyme or group of enzymes to be isolated, and the purity required, methods well known to the specialist can be used to isolate samples of active enzymes from the autolysate, or from appropriate, individual fractions (phases) concentration and/or separation according to molecular size and shape, electrical charge, functional groups, solubility characteristics, or on a.combination of these principles, e.g. membrane technology such as ultrafiltration, gel chromatography, ion exchange chromatography, affinity chromatography, electrophoresis, electrodialysis, precipitation by salts or acids, or selective extraction. Final concentration and removal of solvents from the preparations may be achieved by appropriate methods which do not affect enzyme activity adversly, e.f., membrane technology and freeze drying, respectively.
For the purification of specific enzymes see for instance (peptide hydrolases Osnes Mohr 1985a, 1985b, 1986, Osnes, Ellingsen Mohr 1986, Chen et al 1978, and Hellgren, Mohr Vincent 1985; hyaluronidase, endo-(1,3)-beta-D-glucanase and beta-glucuronidase Karlstam 1987; ribonuclease Van 1982).
Our study in the krill field has revealed that the trypsin-like krill proteases can be affinity purified on benzamidine adsorbents and most probably also on adsorbents to which trypsin inhibitors are bound, the krill carboxypeptidases on .arginine or phenylalanine (hydrophobic) adsorbents and some polysaccharidases on ConA adsorbents (krill hyaluronidase, beta-glucuronidase and endo-(1,3)-beta-D-glucanase).
Example 1 g of frozen, Antarctic krill (Euphausia superba) were thawed at room temperature, and homogenized together with 25 ml of deionised water for 45 sec at room temperature using a Janke Kunkel Homogenizer TP 18. The homogenate was highly viscous and contained a considerable proportion of particulate material. An aliquot of the homogenate was removed for determination of enzyme activity. The homogenate was incubated at 50 C for 20 h at the natural pH (about 7) of the homogenate.
-dA 1 WO 89/01031 8 PCT/SE88/00374 After incubation the homogenate was centrifuged at 13 000 g for 40 min in the cold. The centrifuged homogenate consisted of three distinct, and well-separated phases: a top layer of oil red in colour due to carotenoids, a clear, aqueous middle layer, and a particulate bottom layer. The aqueous.
middle layer was removed with a pipette in the form of a clear solution with low viscosity. An aliquot of the aqueous phase was taken for determination of enzyme activity.
The proteolytic activity of the homogenized krill and of the aqueous phase of the autolysate, was determined with TAME as a substrate according to the method of Rick, 1974 (Methods of Enzymatic Analysis (H.Bergmeyer ed.)2nd.edn., Vol2,pp.
1013-1023. Academic Press, New York). In accordance with the claims of the invention, the aqueous fraction after autolysis at 50 °C for 20 h contained an enzymic activity corresponding to 95 of that of the original homogenate prior to autolysis.
Example 2 ml of the aqueous phase of the krill autolysate prepared according to Example 1 were subjected to ultrafiltration in order to separate the enzyme preparation from low-molecular weight substances. The separation was carried out in an Amicon ultrafiltration unit, using an Amicon Diaflo Ultrafilter type PM 10. The filter effects retention of material with a molecular weight exceeding 10 000. The ultrafiltration was run at a rate of 2.5 ml per sq.cm per hour at room temperature, using a pressure of 1,4 atm. of nitrogen.
Due to the low viscosity of the aqueous fraction of the autolysate, the ultrafiltration proceeded very effectively.
Ultrafiltration was continued until the volume of the autolysate had been reduced to one tenth of the original volume. The high-molecular weight fraction after ultrafiltration contained the enzyme activity, whereas the permeate contained low-molecular weight material, mainly free amino acids and other break-down products after autolysis.
WO 89/01031 -PCT/SE85/00374 Example 3 Squeezed krill was obtained from whole fresh or frozen krill by pressing and centrifuging the raw material. In brief frozen krill, stored at minus 20-30 OC, was allowed to thaw at room temperature for 20 hrs and then centrifuged for 10-30 min at 1 500-3 000 xg to,remove insoluble substances.
The viscous liquid was collected and defined as squeezed krill. The fresh krill was processed in the same way without thawing.
1 000 ml of squeezed krill were subjected to spontaneous autolysis by storing at different temperatures (20-45 °C) and times (10-48 hrs) at different pH-values 6,8-7,0. After terminated incubation the mixtures were centrifuged at 3 500 xg for 60 min. This resulted in partitioning the material into three distinct phases for pH below 8. The middle phase represented by a clear aqueous liquid contained, as in example 2, high levels of hydrolytic enzymes degrading proteins, polysaccharides and polynucleotides. This was removed by sucking and subjected to concentration/purification by membrane filtration. The high molecular weight substances 000 Daltons) were further purified by ion exchange chromatography Q-Sepharose Pharmacia AB, Sweden) or hydrophobic interaction chromatography Phenyl Sepharose® or Alkyl Sepharose®) using continuous or discontinuous salt gradients when eluting different enzymes/proteins. The enzymatic activity was collected for different enzyme groups and desalted by gel filtration or dialysis procedures. In this matter one or several bulk enzyme mixtures were obtained for further isolation and purification of individual hydrolytic enzymes.
The protein content, total proteolytic activity, trypsin-like activity and hyaluronidase activity were followed during the process, see table I-IV. In addition amylase, beta-glucuronidase, endo-(1,3)-beta-D-glucanase and carboxypeptidase activities were measured.
;Er'S r- Table I Summary of autolysis (25 0 C;20h) and partial purification of squeezed krill by membrane filtration and anion exchange chromatography on Q-Sepharose FF Volume Protein Caseinolytic activity Trypsin-like activity Recovery Purification T l Recovery Purification Total Total Sample (ml) units (fold) units (fold) Squeezed krill 1000 40 100 1500 100 1 32000 100 1 Autolysate 760 17 42 1250 83 2 32000 100 2.4 Protein concentrate 95 6 15 1150 77 5 29600 92 6 Enzyme pool after ion exchange chromatography 250 1.5 4 900 60 .16 21700 68 18 i
I
0 Table II- Summary of further purification of serine proteinases from a bulk enzyme mixture isolated from autolysed squeezed krill Protein Trypsin-like activity Step Volume Total Spec. act. Recovery Purification (mlI) (mg/mil) Total mg (U/mi) units (U/mg p~rotein) ()(fold) Bulk enzyme 9 6.5 58.5 68 612 10.5 100 1 IBenzamidine- Sepharose 6B 21 0.5 10.5 215 525 50 86 4.8 Sephadcx (G-25 4:i 0.24 10.3 10 4310 42 70 4 Protein concentrate 8.6 0.8 6.9 43 370 54 60 5.1 Table-III Protein degradation Effect of temperature Temperature Protein residues I.C) 0 B (no autRlysis) 12-21 12-17 8-17 Effect of time Time Protein residues 0 100 10 20-25 20 10-20 48 10-20 Exper-iments performed for 20 h. Experiments performed at
U
Table-IV Stimury of further purificioit of hyaluronidase from a bulk enzyme mixture isolated from autolysed squeezed krill Stepj Volumei (m 1) P rotc i (Ing/ml) Tlotal mg (U/mi) 'Total units Spec.act.
(U/mg protein) F llyalurotiidase activity Recovery Purification (fold) Bulk enzyme 77 5 :385 140 10780 28 100 1 Con A-Sepliarose 43 1.2 52 68 2924 57 27 2 Protein concentrate 10 4.1 41 291 2910 71 27 -YM 10 filter Superose 6 26 0.6 16 59 1534 98 14 FPLC-Mono Q HR 10/10 22 0.47 10 63 1386 134 13 4.8 -YM 10 filter____
I
WO 89/01031 14 PCT/SE88/00374 Referenslista Chen et al., 1978: J. Food Biochem. 2, p 349-66.
Chen Gau, 1981: J. Food Biochem. 5, p 63-8.
Ellingsen Mohr, 1979: Process Biochem. 14 p 14.
Ellingsen, 1982: Biochemical Studies on Antarctic Krill (Ph. D. Thesis) Department of Biochemistry, The Norwegian Institute of Technology, The University of Trondheim.
Ellingsen Mohr, 1987: Biochem. J. In press.
Hellgren, Mohr Vincent, 1986: Experentia 42, p 403-4.
Hellgren, Mohr Vincent, 1987: 17th World Congr.
Dermatol., Berlin, p 196.
Hellgren, Mohr Vincent, 1985: WO-A-85/04809.
Karlstam, 1988: EP-A-252,044 (Pharmacia AB).
Nagayama et al., 1979: Transactions of the Tokyo University of Fisheries 3, p 153-159.
Osnes Mohr, 1985a: Comp. Biochem. Physiol. 82B, p 599-606.
Osnes Mohr, 1985b: Comp. Biochem. Physiol. 82B, p 607-19.
Osnes Mohr, 1986: Comp. Biochem. Physiol. 83B, p 445-458.
Osnes, Ellingsen Mohr, 1986: Comp. Biochem.
Physiol. 83B, p 802-5.
WO 89/01031 15 PCT/SE88/00374 Rick, 1974: Methods of Enzymatic Analysis (ed.: H. Bergmeyer) 2nd edn., vol 2 pp 1013, 1023.
Saether, 1986: Biochemistry of North Atlantic Krill.
(Ph. D. Thesis) Department of Biochemistry, The Norwegian Institute of Technology, The University of Trondheim.
Saether, Ellingsen Mohr, 1987: Comp. Biochem.
Physiol. In press.
Van, 1982: Agric. Biol. Chem. 46, p 691-6.
IA.
o i
LL-

Claims (2)

  1. 349-366, (CHING-SAN CHEN), "Purification and properties of tryspsin-like enzymes and a carboxypeptidase a from euphausia superba" Special categories of cited documenta: 10 later document published after the international filing date or priority date and not In conflict with the application but document defining the general state of the art which Is not or prt underat and the princniflctor theory underlying th conaidered to be of particular relevance invention earlier document hut published on or after the International document of particular relevance; the claimed invention filing date cannot be considered novel or cannot be considered to document which may throw doubts on priority claim(a) or involve an inventive step which is cited to establish the publication date of another document of particular relevance; the claimed invention citation or other special reason (as specified) cannot be considered to involve an inventive step when the document referring to an oral disclosure, use, exhibition or document Is combined with one or more other such docu- other means manta, such combination being obvious to a person skilled document published prior to the international filing dat but in the art. later than the priority date claimed document member of the same patent family IV. CERTIFICATION Date of the Actual Completion of the international Search Date of Mailing of this International Search Report
  2. 1988-10-10 1988 -10- 19 International Searching Authority SI turo of Authorlzed O cer Swedish Patent Office vonne Si6 oseen Form PCT/ISAi210 Isecond sheet) (January 1985) within the above-mentioned limits in order to reach the best qualilty and yield. IE II EU II. urn II U. I International Application No. P C T S E 88B 00 37 4 ~1 Ill. DOCUMENTS CONSIDERED TO BE RELEVANT (CONTINUED FROM THlE SECOND SHEET) category Citation of Document, with indiction, where appropriate. of the relevaent passages Relevant to Claim No A Comp.Biochem.Physiol.Vol 83B, No 4, pp 801 805, 1986, (KNUT KR. OSNES), "Hydrolysis of proteins by peptide hydro- lases of antarctic krill, euphausia superba"l Form PCT!ISA,1210 (extra shieet) (JanuwT IMS)
AU22597/88A 1987-08-06 1988-07-08 Method for the isolation of active enzyme(s) from krill tissue Ceased AU618962B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8703064A SE8703064D0 (en) 1987-08-06 1987-08-06 METHOD FOR ISOLATING ACTIVE ENZYME PREPARATIONS FROM ANIMAL TISSUES
SE8703064 1987-08-06
PCT/SE1988/000374 WO1989001031A1 (en) 1987-08-06 1988-07-08 Method for the isolation of active enzyme(s) from krill tissue

Publications (2)

Publication Number Publication Date
AU2259788A AU2259788A (en) 1989-03-01
AU618962B2 true AU618962B2 (en) 1992-01-16

Family

ID=26659904

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22597/88A Ceased AU618962B2 (en) 1987-08-06 1988-07-08 Method for the isolation of active enzyme(s) from krill tissue

Country Status (1)

Country Link
AU (1) AU618962B2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695457A (en) * 1984-04-24 1987-09-22 Pharmacia Ab Enzyme composition acting as a digestion promoter on various levels in the alimentary tract, and a method for facilitating digestion

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695457A (en) * 1984-04-24 1987-09-22 Pharmacia Ab Enzyme composition acting as a digestion promoter on various levels in the alimentary tract, and a method for facilitating digestion

Also Published As

Publication number Publication date
AU2259788A (en) 1989-03-01

Similar Documents

Publication Publication Date Title
EP0393035B1 (en) Method for the isolation of active enzyme(s) from krill tissue
REDDI et al. Catheptic activity of fish muscle
Heymann et al. [45] Carboxylesterases-amidases
EP0695350B1 (en) Process for purifying collagenase
Jones The free amino acids of fish. 1-Methylhistidine and β-alanine liberation by skeletal muscle anserinase of codling (Gadus callarias)
US6346245B1 (en) Procedure for extraction and use of hatching fluid from Atlantic salmon
McDonald et al. [22] Preparation and specificity of dipeptidyl aminopeptidase I
WO1989010960A1 (en) Method for modifying proteins, peptides and/or lipids by enzymes from euphauciaceae
Pacaud Identification and localization of two membrane-bound esterases from Escherichia coli
AU618962B2 (en) Method for the isolation of active enzyme(s) from krill tissue
US2808362A (en) Preparation of hyaluronidase
US5192677A (en) Alkali and heat stable protease from thermomonospora fusca
Yokosawa et al. Isolation and characterization of a post-proline cleaving enzyme and its inhibitor from sperm of the ascidian, Halocynthia roretzi
Kubo et al. DEACETYLATION OF PS-5, A NEW β-LACTAM COMPOUND II. SEPARATION AND PURIFICATION OF L-AND D-AMINO ACID ACYLASES FROM PSEUDOMONAS SP. 1158
Schocher et al. Composition of purified mucopeptide from the wall of Aerobacter cloacae
Kramer et al. [35] Assay and purification of phospholipase A2 from human synovial fluid in rheumatoid arthritis
Keck et al. Comparison of two hydrolytic murein transglycosylases of Escherichia coli
Ferreira et al. Minor aminopeptidases purified from the plasma membrane of midgut caeca cells of an insect (Rhynchosciara americana) larva
ETINGOF Characterization and partial purification of mating pheromone excreted by mating type II cells of the ciliate Dileptus anser
MacGregor et al. Isolation and characterisation of discoid granules from the tegument of adult Schistosoma mansoni
US4390629A (en) Polypeptide degrading enzymes
Reboud et al. Partial in vitro reconstitution of active 40S ribosomal subunits from rat liver
US20020064857A1 (en) Non-selfdegrading endoprotease
Bhargava et al. Comparison of hemorrhagic factors of the venoms of Naja naja, Agkistrodon piscivorus and Apis mellifera
Rhodes et al. Ascaris suum: Purification and characterization of an intestinal aminopeptidase